October 2013 Issue Table Of Contents

From The Editor

• Drug Take-Back Programs – Coming To A Municipality Near You

Ask The Board

• Ask The Board October 2013

Capitol Perspectives

• Raising Co-Pays On Low-Income Beneficiaries’ Drugs Not A Solution

Companies To Watch

• Invio And Roche Form Research Partnership For DNA-Based Vaccines

Outsourcing Insights

• API Manufacturing: Strategic Partnering Preferences With CMOs Vary Among Small-Molecule, High-Potency And Biologic API

Bio Innovation notes

• Innovation In Alternative Chromatography

Feature

• Teva Explores The Common Ground Of Follow-On And Innovative Pharma
• Do The Right Thing: GSK’s Case For Data Transparency
• The Art Of The Turnaround In Phama

Inside The Industry

• Designing A Brand Protection Organization In Life Sciences
• Why Do Drugs Fail To Reach The Market?
• Strategic Approaches To Risk-Based Monitoring In Clinical Trials
• Adaptive Clinical Design Addresses The Uncertainties
• Pharmaceutical Market Access In Brazil

Industry Leader

• Access To Big Data Accelerates Discovery And Cuts Drug Development Costs
• How To Strengthen Biotech’s Pipeline? Partner With Academia
• The Benefits Of Building A Cognitively Diverse Team In Life Sciences